021-51111890
购物车（0）
sales@molnova.cn
GSK-2879552
CAS No. 1401966-69-5
GSK-2879552 ( GSK2879552 )
产品货号. M11677 CAS No. 1401966-69-5
一种有效的、选择性不可逆的 LSD1 抑制剂，Ki app 为 1.7 uM。
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 2MG | ￥381 | 有现货 |
|
| 5MG | ￥591 | 有现货 |
|
| 10MG | ￥948 | 有现货 |
|
| 25MG | ￥1652 | 有现货 |
|
| 50MG | ￥2989 | 有现货 |
|
| 100MG | ￥5613 | 有现货 |
|
| 200MG | 获取报价 | 有现货 |
|
| 500MG | 获取报价 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称GSK-2879552
-
注意事项本公司产品仅用于科研实验，不得用于人体或动物的临床与诊断
-
产品简述一种有效的、选择性不可逆的 LSD1 抑制剂，Ki app 为 1.7 uM。
-
产品描述A potent, selective irreversible inhibitor of LSD1 with Ki app of 1.7 uM; shows good selectivity against LSD2, MAO-A, MAO-B, D-amino acid oxidase and LoxL2; exhibits growth inhibition (EC50=2-240 nM) in sensitive cell lines; orally bioavailable.Lung Cancer Phase 1 Clinical.
-
体外实验Cell Proliferation Assay.Cell Line:9/28 small cell lung carcinoma (SCLC) lines and 20/29 AML lines. Concentration:0-10000 nM.Incubation Time:6 days.Result:Inhibited cell proliferation.RT-PCR.Cell Line:Resistant HCC cells (PLC/PRF/5 and Huh7). Concentration:0, 1, 2 μM.Incubation Time:24 h.Result:Displayed reduced mRNA expression levels of stem cell markers, such as Lgr5, Sox9,Nanog and CD90, and elevated mRNA expression levels of differentiation markers Alb and Hnf4.
-
体内实验Animal Model:NCI-H526 and NCI-H1417 xenografts.Dosage:1.5 mg/kg.Administration:PO daily for 25-35 days.Result:There was 57% and 83% tumor growth inhibition (TGI) in NCI-H526 and NCI-H1417 tumor bearing mice respectively. NCI-H510 and NCI-H69 tumor bearing mice also demonstrated partial TGI (38% and 49% respectively) in response to GSK2879552, while no significant TGI was observed for SHP77 bearing mice.
-
同义词GSK2879552
-
通路Chromatin/Epigenetic
-
靶点Histone Demethylase
-
受体LSD1
-
研究领域Cancer
-
适应症Lung Cancer
化学信息
-
CAS Number1401966-69-5
-
分子量364.4806
-
分子式C23H28N2O2
-
纯度>98% (HPLC)
-
溶解度10 mM in DMSO
-
SMILESO=C(O)C1=CC=C(CN2CCC(CN[C@H]3[C@H](C4=CC=CC=C4)C3)CC2)C=C1
-
化学全称Benzoic acid, 4-[[4-[[[(1R,2S)-2-phenylcyclopropyl]amino]methyl]-1-piperidinyl]methyl]-
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1. Mohammad HP, et al. Cancer Cell. 2015 Jul 13;28(1):57-69.
2. Huang M, et al. Cancer Lett. 2017 Jul 10;398:12-21.
3. Maes T, et al. Epigenomics. 2015;7(4):609-26.
产品手册
关联产品
-
LSD1-IN-7 benzenesul...
LSD1-IN-7 苯磺酸盐是一种有效的口服活性赖氨酸特异性去甲基化酶 1 (LSD1) 抑制剂，具有抗癌活性。
-
IOX1
IOX1 是 2OG 加氧酶（包括 JmjC 去甲基酶）的有效广谱抑制剂。
-
LSD1-IN-27
LSD1-IN-27 (Compound 5ac) 是一种 LSD1 抑制剂 (IC50: 13 nM)。LSD1-IN-27 抑制胃癌细胞的干细胞性和迁移。LSD1-IN-27 还可降低 BGC-823 和 MFC 细胞中 PD-L1 的表达。LSD1-IN-27 可增强对胃癌的 T 细胞免疫反应。
